With further analysis, we also observed that the expression of SPA17 was higher in patients with lymph node metastasis (55.6%), Cox regression analysis showed SPA17 was an independent factor associated with DFS and OS in breast cancer patients. Here, SPA17 is linked to breast carcinoma.